Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas

Clinical trial NCT03600649 · UNKNOWN

Trial details

NCT number: NCT03600649
Sponsor: Salarius Pharmaceuticals, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Ewing Sarcoma Myxoid Liposarcoma Sarcoma,Soft Tissue Desmoplastic Small Round Cell Tumor Extraskeletal Myxoid Chondrosarcoma Angiomatoid Fibrous Histiocytoma Clear Cell Sarcoma Primary Pulmonary Myxoid Sarcoma Myoepithelial Tumor Sclerosing Epithelioid Fibrosarcoma Fibromyxoid Tumor

Start date: 2018-06-04
Primary completion: 2025-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.